Bio Chips Market Size, Share Global Analysis Report, 2020–2026

Industry Insights

The Bio Chips market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire Bio Chips market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of both values (USD Billion) from FY 2016 – 2026.

This technical and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the Bio Chips industry. The report analyzes and declares the historical and current trends analysis of the Bio Chips industry and subsequently recommends the projected trends anticipated to be observed in the Bio Chips market during the upcoming years.

Key Insights from Primary Research

• As per our primary respondents, the Bio Chips market is set to grow annually at a rate of around 21.1%.
• It was established through primary research that the Bio Chips market was valued at around USD 14.7 billion in 2019.
• After secondary research, we performed face-to-face interviews to validate our data. The insights interviewees declared that DNA Chip is the most used product for the global Bio Chips market.
• On the basis of the application, Drug Discovery and Development dominated the global Bio Chips market in 2019. It accounted for around 23% share of the total market in 2019.
• The Hospitals and Diagnostics Centers segment, on the basis of end-user segmentation, was the leading revenue-generating category accounting for around 37% share, in 2019.

Key Recommendations from Analysts

• Based on the exhaustive secondary research done by our team, the Hospitals, and Diagnostics Centers type is anticipated to become the most demanding type in the upcoming years, owing to the growing demand for Bio Chips from the biomedical industry for various end-use applications.
• As per our analysts, North America recorded the highest market share of more than 33% by 2026, and the market is expected to bolster in this region, resulting in creating lucrative opportunities for new players.
• Growing at a CAGR of around 21.1%, the Bio Chips market provides numerous opportunities for all of the involved stakeholders across the entire value chain.
• Our analysts have identified DNA Chip and Drug Discovery and Development categories as the leading investment pockets for the Bio Chipsmarket in terms of product and application segmentation respectively.
• Our analysts recommend the emerging players focus on Drug Discovery and Development owing to the substantial growth of the biomedical industry, especially in APAC and Middle-eastern regions.

Market Attractiveness – By End-User

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Bio Chips industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Bio Chips industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Bio Chips market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Bio Chips industry. The Bio Chips market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Bio Chips sector. Key strategic developments in the Bio Chips market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Bio Chips market are appropriately highlighted in the report.

Bio Chips market accounted for approximately USD 14.7 billion in 2019. The market is projected to grow at a CAGR of 21.1% and is anticipated to reach around USD 56.5 by 2026

Growing incidence of cancer, increased government support, R&D investment in biotechnology, increased interest in personalized medicines and a significant increase in regional health expenditure, technical innovation in biotechnology and increased use of biochips are some of the key factors that stimulate market development.

However, increased government support and investment in research and development in the biotech sector are the primary drivers of growth in the global biochip market. In many countries, private companies and governments have become increasingly aware of the many advantages of biotechnology. All of these bodies are also active in biotechnological-related investments.

The Bio Chips market research report delivers an acute valuation and taxonomy of the Bio Chips industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the Bio Chips industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the Bio Chips industry is provided for the leading economies of the world.

The Bio Chips market is segmented based on Product, Application, and End-user.  On the basis of product segmentation, the market is classified into DNA Chips, Protein Chips, Lab-on-Chip, and Others. In terms of Application segmentation, the market is bifurcated into Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others. By the end-user, the market is bifurcated into, Biotechnology and Pharmaceutical Sector, Hospitals and Diagnostics Centers, Academic and Research Institutes, and Others.

Report Scope

Some of the essential players operating in the Bio Chips market, but not restricted to include

•  Horiba Ltd.
•  Fluidigm Corporation
•  PerkinElmerInc.
•  Dynamic Biosensors GmbH
•  OriGene Technologies Inc.
•  Illumina Inc.
•  Bio-Rad Laboratories Inc.
•  Qiagen N.V.
•  Thermo Fisher Scientific Inc.
•  Randox Laboratories Limited

The taxonomy of the Bio Chips industry by its scope and segmentation is as follows:

By Product Segmentation Analysis (Customizable)

• DNA Chip
• Protein Chip
• Lab-on-Chip
• Other

By Application Segmentation Analysis (Customizable)

• Drug Discovery and Development
• Disease Diagnostics
• Genomics
• Proteomics
• Agriculture
• Others

By End-User Segmentation Analysis (Customizable)

• Biotechnology and Pharmaceutical Sector
• Hospitals and Diagnostics Centers
• Academic and Research Institutes
• Others

Regional Segmentation Analysis (Customizable)

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of the Middle East & Africa